- Filed
- Mar 6, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2019 · Mar 3, 2020 | 39.29M sh |
| Shares Diluted | FY 2019 · Dec 31, 2018 | 38.9M sh |
| Capex | FY 2019 · Dec 31, 2018 | $6.26M |
| Operating Cash Flow | FY 2019 · Dec 31, 2018 | $2.06M |
| Cash And Equivalents | FY 2019 · Dec 31, 2018 | $15.92M |
| Current Liabilities | FY 2019 · Dec 31, 2018 | $36.02M |
| Total Liabilities | FY 2019 · Dec 31, 2018 | $40.29M |
| Current Assets | FY 2019 · Dec 31, 2018 | $45.27M |
| Total Assets | FY 2019 · Dec 31, 2018 | $91.46M |
| Eps Diluted | FY 2019 · Dec 31, 2018 | −$0.19 |
| Eps Basic | FY 2019 · Dec 31, 2018 | −$0.19 |
| Sga Expense | FY 2019 · Dec 31, 2018 | $19.45M |
| Rd Expense | FY 2019 · Dec 31, 2018 | $23.75M |
| Net Income | FY 2019 · Dec 31, 2018 | −$7.56M |
| Net Income | FY 2019 · Dec 31, 2018 | −$7.56M |
| Operating Income | FY 2019 · Dec 31, 2018 | −$6.39M |
| Revenue | FY 2019 · Dec 31, 2018 | $143.88M |
| Revenue | FY 2019 · Dec 31, 2018 | $143.88M |
| Stockholders Equity restated | FY 2019 · Dec 31, 2017 | $54.68M |